Press release: Appointment of Dr Patrick Vallance as government Chief Scientific Adviser

The Cabinet Secretary is pleased to announce the appointment of Dr Patrick Vallance as the new government Chief Scientific Adviser. Dr Vallance, who is currently President of Research and Development, at GlaxoSmithKline, and the former Head of Medicine at University College London, was chosen following an open competition. He will take up the post in Spring 2018. Professor Chris Whitty, Chief Scientific Adviser for the Department of Health, is carrying out the role on an acting basis.

The Cabinet Secretary, Sir Jeremy Heywood said:

This is an excellent appointment for the Civil Service, in an important area of government business. Patrick Vallance has already advised the government on several occasions in his capacity as a Member of the UK Ministerial Industry Strategy Group, so he is well placed to offer the best scientific advice available to the Prime Minister and other members of the Cabinet. I am also looking forward to the contribution Patrick will make in leading the science community across government, building on the great work of Sir Mark Walport, his predecessor.

I would also like to take this opportunity to thank Sir Mark for the invaluable contribution he has made to policy development and strengthening Whitehall’s already world-class science capability.

Commenting on his new role, Dr Patrick Vallance said:

It is a great honour to join the Civil Service as the Government Chief Scientific Adviser. Science, engineering and technology have a vital role to play at the heart of policy making and are critical to economic growth and prosperity in the UK as well as to addressing many of the greatest challenges of our time, such as environmental change and keeping our citizens healthy and secure.

I look forward to working with colleagues to ensure the government has the best possible advice, from the best experts, based on the strongest evidence, to inform the widest range of policy decisions.

Science Minister, Jo Johnson said:

Science and innovation plays a pivotal role in our Industrial Strategy and we’ve invested an additional £4.7 billion to 2020/21 to ensure we continue to build on our worldwide reputation as a science powerhouse. Dr Patrick Vallance’s extensive knowledge and experience from the private sector and academia will play a central role in supporting this commitment and promoting our global leadership status.